ArticleOncotarget2015
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells.
Irene Ischenko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it
ArticleOncotarget2015
Irene Ischenko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.